InvestorsHub Logo
Followers 33
Posts 491
Boards Moderated 0
Alias Born 10/11/2007

Re: vator post# 501468

Friday, 08/05/2022 8:12:19 AM

Friday, August 05, 2022 8:12:19 AM

Post# of 700921
Vater. These type of trials are very difficult because this cancer is so malignant and kills pretty much everybody.

So nobody will sign up for a clinical trial if there’s a chance that they’re going to be on the placebo arm. Everybody wants the new experimental treatment. Hence our trial provided the crossover so that the placebo patience would Have a chance at getting the experimental therapy. This allowed the trial to be completed because had that not been in place the trail would’ve failed because no one would have signed up for being on the trial.

Bottom line though Vater is this is extremely positive DATA I am clearly certain this will be approved and be made available to patients. It’s obvious the company is ramping up production. I don’t know when.

I too sometimes get frustrated waiting for the journal. But I think there’s multiple balls in the air at this point in time. Really everything has been positive lately, the New York Academy of sciences presentation, the stuff happening over in England, the intellectual property protection. It all adds up to extremely positive things for this company.

I block all of those malicious posters who never add anything new. I also block anybody who brings up Enron with regard to Linda Powers because Her motivations I know to see this succeed are personal having seen Her father die from GBM.

The only negative for me is I can’t offer it to patients now who are really in need. It’s sad to see them die from this disease without the opportunity of getting this new in exciting dendritic cell vaccine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News